These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10942789)

  • 1. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.
    Mustonen P; Savola J; Lassila R
    Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]atipamezole as a radioligand for alpha 2-adrenoceptors.
    Sjöholm B; Voutilainen R; Luomala K; Savola JM; Scheinin M
    Eur J Pharmacol; 1992 Apr; 215(1):109-17. PubMed ID: 1355439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.
    Matsukawa T; Hikasa Y
    Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
    Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
    Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
    Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.
    Yokota S; Hikasa Y; Shimura I; Kusunose S
    Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
    Reynen PH; Martin GR; Eglen RM; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(7):1339-46. PubMed ID: 10742289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
    Virtanen R; Savola JM; Saano V
    Arch Int Pharmacodyn Ther; 1989; 297():190-204. PubMed ID: 2567152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
    Schloos J; Wellstein A; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-adrenergic binding of [3H]atipamezole in rat kidney--regional distribution and comparison to alpha2-adrenoceptors.
    Sjöholm B; Lähdesmäki J; Pyykkö K; Hillilä M; Scheinin M
    Br J Pharmacol; 1999 Nov; 128(6):1215-22. PubMed ID: 10578134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.
    Berlan M; Le Verge R; Galitzky J; Le Corre P
    Br J Pharmacol; 1993 Apr; 108(4):927-32. PubMed ID: 8097957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
    Yokota S; Hikasa Y; Mizushima H
    Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.
    Schwartz DD; Clark TP
    J Vet Pharmacol Ther; 1998 Oct; 21(5):342-7. PubMed ID: 9811433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.